Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
Highlights: Revenue of $145.2 million up 56% sequentially in quarter ended Sept. 30, 2020 GAAP operating income increased $28.7 million...